# Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.

> **NCT03047278** · PHASE4 · COMPLETED · sponsor: **Natalia Valadares de Moraes** · enrollment: 29 (actual)

## Conditions studied

- Neuropathic Pain
- Type 2 Diabetes Mellitus
- Diabetic Neuropathy, Painful

## Interventions

- **PROCEDURE:** Serial Blood Samples
- **PROCEDURE:** Serial Urine Samples
- **DRUG:** Gabapentin 300 mg
- **DRUG:** Cetirizine Hydrochloride 10 mg

## Key facts

- **NCT ID:** NCT03047278
- **Lead sponsor:** Natalia Valadares de Moraes
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-01
- **Primary completion:** 2018-05-01
- **Final completion:** 2019-07-01
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2019-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03047278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03047278, "Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03047278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*